The effect of Elaeagnus angustifolia gel on knee osteoarthritis

Phase 3

• Conditions: Knee osteoarthritis.; Osteoarthritis, unspecified site; M19.9

• Registration Number: IRCT20221212056787N1
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 112

Inclusion Criteria

Osteoarthritis patients aged 40 to 75 years of both sexes with non-traumatic knee pain who were graded II and III based on the K-L scale in radiographs of the last 6 months.

Exclusion Criteria

Patients with a history of joint damage, uncontrolled blood pressure, osteoarticular diseases (diabetes, rheumatism, osteonecrosis and gout)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome: questionnaire score WOMAC ( Western Ontario and McMaster Universities Osteoarthritis Index). Timepoint: At the beginning of the study (before the start of the intervention) and in the fourth and eighth weeks after the treatment with elderberry gel. Method of measurement: questionnaire WOMAC.